机译:Entecavir与Adefovir联合改善患有慢性乙型肝炎的患者,患有核苷酸(酸)模拟单药治疗
Sun Yat Sen Univ Affiliated Hosp 3 Dept Infect Dis 600 Tianhe Rd Guangzhou 510630 Guangdong;
Southern Med Univ Affiliated Hosp 3 Clin Dept Guangzhou Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 3 Dept Infect Dis 600 Tianhe Rd Guangzhou 510630 Guangdong;
Sun Yat Sen Univ Affiliated Hosp 3 Dept Infect Dis 600 Tianhe Rd Guangzhou 510630 Guangdong;
Sun Yat Sen Univ Affiliated Hosp 3 Dept Infect Dis 600 Tianhe Rd Guangzhou 510630 Guangdong;
Sun Yat Sen Univ Affiliated Hosp 5 Dept Infect Dis Zhuhai Peoples R China;
Sun Yat Sen Univ Affiliated Hosp 3 Dept Infect Dis 600 Tianhe Rd Guangzhou 510630 Guangdong;
Sun Yat Sen Univ Affiliated Hosp 3 Dept Infect Dis 600 Tianhe Rd Guangzhou 510630 Guangdong;
Sun Yat Sen Univ Affiliated Hosp 3 Dept Infect Dis 600 Tianhe Rd Guangzhou 510630 Guangdong;
Sun Yat Sen Univ Affiliated Hosp 3 Dept Infect Dis 600 Tianhe Rd Guangzhou 510630 Guangdong;
Sun Yat Sen Univ Affiliated Hosp 3 Dept Infect Dis 600 Tianhe Rd Guangzhou 510630 Guangdong;
nucleotide (acid) analogs; chronic hepatitis B; entecavir; adefovir; optimal treatment;
机译:Entecavir与Adefovir联合改善患有慢性乙型肝炎的患者,患有核苷酸(酸)模拟单药治疗
机译:Tenofovir Disoproxil Mumarate单疗法优于Entecavir-Adefovir在次级响应器中用于慢性乙型肝炎患者RT204i / V突变患者的次思别响应者:96周的前瞻性多中心试验
机译:恩替卡韦联合阿德福韦酯治疗2年的慢性乙型肝炎患者在先前的核苷酸(t)ide类似物治疗失败的情况下的疗效
机译:基于拉米夫定转为阿德福韦酯和恩替卡韦抗乙型肝炎感染治疗的数学模型
机译:慢性乙型肝炎患者乙型肝炎表面抗原血管疮的发病率,耐久性和临床结果
机译:优化的联合用阿德福韦酯(ADV)和拉米夫定替比夫定或恩替卡韦的联合疗法可能对慢性乙型肝炎患者有效对ADV单一疗法的反应不佳
机译:Entecavir Plus endefovir组合治疗与EndeFavir单药治疗的长期疗效与Adefovir难治性慢性乙型肝炎患者的先前拉米夫拉耐药性
机译:标准变量无法识别热损伤后无法应对液体复苏的患者:简要报告。